| BioID | bio14806 |
|---|
| Name | TASELISIB |
|---|
| ChEMBL ID | CHEMBL2387080 |
|---|
| Molecular Formula | C24H28N8O2 |
|---|
| Molecular Weight | 460.54 |
|---|
| Molecular Weight (Monoisotopic) | 460.2335 |
|---|
| Type | Small molecule |
|---|
| Max Phase | Phase 3 |
|---|
| Target ID | Tar16 |
|---|
| Target Name | GABA transporter-3 (SLC6A11) |
|---|
| Synonyms | GDC-0032|RG-7604|TASELISIB|Taselisib |
|---|
| Smiles | Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1 |
|---|
| Inchi | InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33) |
|---|
| Inchi Key | BEUQXVWXFDOSAQ-UHFFFAOYSA-N |
|---|
| Molecular Species | NEUTRAL |
|---|
| Targets | 40.0 |
|---|
| Bioactivities | 887.0 |
|---|
| Np Likeness Score | -1.08 |
|---|
| Records Key | ['TASELISIB', 'TASELISIB', '11l, GDC-0032', '3; GDC-0032; taselisib', 'TASELISIB', 'TASELISIB', 'Taselisib', 'Taselisib', 'TASELISIB', 'GDC0032', 'EUB0000685a', 'EUB0000685a', 'EUB0000685a', 'EUB0000685a', 'GDC-0032', 'EOS100674', 'Taselisib', 'EUB0000685a'] |
|---|
| Records Name | ['TASELISIB', 'TASELISIB', '2-{3-[2-(1-Isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide', '2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide', 'TASELISIB', 'TASELISIB', 'Taselisib', 'Taselisib', 'TASELISIB', '2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide', 'Taselisib', 'Taselisib', 'Taselisib', 'Taselisib', 'Taselisib', 'TASELISIB', 'Taselisib', 'Taselisib'] |
|---|
| Withdrawn Flag | False |
|---|
| Orphan | 0 |
|---|
